Outcomes of Patients with Splenic Marginal Zone Lymphoma Treated with Rituximab or Splenectomy: Report from Tertiary Cancer Center in India

被引:0
|
作者
Bagal, Bhausaheb [1 ]
Mandal, Tanmoy [1 ]
Bonda, Avinash [1 ]
Punatar, Sachin [1 ]
Gokarn, Anant [1 ]
Tembhare, Prashant [1 ]
Jain, Hasmukh [1 ]
Patkar, Nikhil [1 ]
Epari, Sridhar [1 ]
Sengar, Manju [1 ]
Khattry, Navin [1 ]
Shet, Tanuja [1 ]
Gujral, Sumit [1 ]
Banavali, Shripad [1 ]
机构
[1] Tata Mem Hosp, Bombay, Maharashtra, India
关键词
Splenic marginal zone lymphoma; Splenectomy; Rituximab;
D O I
10.1016/j.clml.2018.07.216
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NHL-185
引用
收藏
页码:S282 / S283
页数:2
相关论文
共 40 条
  • [31] t(14;22)(q32;q11) translocation involving IGH and IGL acquired at progression of splenic marginal zone lymphoma treated with rituximab, ibrutinib, and obinutuzumab
    Geyer, Julia T.
    Ruan, Jia
    Kluk, Michael J.
    Bao, Liming
    ANNALS OF HEMATOLOGY, 2025, : 2005 - 2011
  • [32] Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center
    Samir Dalia
    Peter Forsyth
    Julio Chavez
    Samantha Price
    Bijal Shah
    Celeste Bello
    Lubomir Sokol
    Edward Pan
    Eduardo Sotomayor
    Ji-Hyun Lee
    Kate Fisher
    Michael Jaglal
    International Journal of Hematology, 2014, 99 : 450 - 456
  • [33] Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center
    Dalia, Samir
    Forsyth, Peter
    Chavez, Julio
    Price, Samantha
    Shah, Bijal
    Bello, Celeste
    Sokol, Lubomir
    Pan, Edward
    Sotomayor, Eduardo
    Lee, Ji-Hyun
    Fisher, Kate
    Jaglal, Michael
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (04) : 450 - 456
  • [34] Impact of Rituximab and IPI on survival in diffuse large B cell Lymphoma patients treated at a tertiary level cancer centre in Pakistan: A single-centre experience
    Athar, Sohail
    Siddiqui, Neelam
    Rai, Sulaman Raza
    Muzaffar, Narjis
    Hameed, Abdul
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (02) : 170 - 174
  • [35] Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study
    Muntanola, Ana
    Teresa Villalobos, Maria
    Gonzalez-Villambrosia, Sonia
    Rodriguez-Salazar, Maria Jose
    Jimenez-Ubieto, Ana
    Bastidas-Mora, Gabriela
    Cordoba, Raul
    Infante, Maria
    Jesus Vidal, Maria
    Javier Diaz, Francisco
    Baile, Monica
    Bastos-Oreiro, Mariana
    Panizo, Carlos
    Manuel Sancho, Juan
    Navarro, Belen
    Garcia, Tomas
    Escoda, Lourdes
    Abrisqueta, Pau
    Terol, Maria Jose
    de Campo, Raquel
    Mozas, Pablo
    Lopez-Guillermo, Armando
    Salar, Antonio
    Montalban, Carlos
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (04) : 776 - 784
  • [36] Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India
    Gogia, Ajay
    Nair, Sukesh
    Arora, Shalabh
    Kumar, Lalit
    Sharma, Atul
    Gupta, Ritu
    Biswas, Ahitagni
    Mallick, Saumyaranjan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center
    Huang, Haobo
    Fan, Liping
    Fu, Danhui
    Lin, Qiuyan
    Shen, Jianzhen
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 1442 - 1452
  • [38] CENTRAL NERVOUS SYSTEM INTERNATIONAL PROGNOSTIC INDEX IMPACTS OVERALL SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH R-CHOP IN A THIRD LEVEL CANCER CENTER FROM MEXICO: A SURVEY OF 642 PATIENTS
    Solis-Armenta, Ruben
    Cacho-Diaz, Bernardo
    Gutierrez-Hernandez, Olga
    Candelaria-Hernandez, Myrna
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (04): : 231 - 237
  • [39] A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children's Cancer Group
    Gao, Yi-Jin
    Fang, Yong-Jun
    Gao, Ju
    Yan, Jie
    Yang, Liang-Chun
    Liu, Ai-Guo
    Ju, Xiu-Li
    Lu, Jun
    Han, Ya-Li
    Wang, Jun
    Xie, Min
    Guo, Xia
    Tang, Jing-Yan
    ANNALS OF HEMATOLOGY, 2022, 101 (09) : 2035 - 2043
  • [40] A prospective multicenter study investigating rituximab combined with intensive chemotherapy in newly diagnosed pediatric patients with aggressive mature B cell non-Hodgkin lymphoma (CCCG-BNHL-2015): a report from the Chinese Children’s Cancer Group
    Yi-Jin Gao
    Yong-Jun Fang
    Ju Gao
    Jie Yan
    Liang-Chun Yang
    Ai-Guo Liu
    Xiu-Li Ju
    Jun Lu
    Ya-Li Han
    Jun Wang
    Min Xie
    Xia Guo
    Jing-Yan Tang
    Annals of Hematology, 2022, 101 : 2035 - 2043